Note: Ingredients listed on restricted chemical lists
EC/CAS
69-65-8
Name of the chemical
D-mannitol C6H14O6
Concentration
N/A
EC/CAS
9005-25-8
Name of the chemical
Starch
Concentration
N/A
EC/CAS
9003-39-8
Name of the chemical
polyvinylpyrrolidone
Concentration
N/A
General Information
Revision date
2018-08-02
Product name
Orilissa (Elagolix) 150 and 200 mg Tablets
Product Synonyms
ABT-620 (Elagolix) RC2 Tablets; Elagolix Tablets; ABT-620 Tablets
supplier name
AbbVie Inc
Icons in SDS
Company Information
company name
AbbVie Inc
e-mail address of the competent person responsible for the Safety Data Sheet
AbbVie.SDS@abbvie.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H319, H360
Hazard statements
Code
Statements
H319
Causes serious eye irritation
Section 2
2.1 Classification of the substance or mixture
Regulation (EC) No 1272/2008 Serious eye damage/eye Category 2 irritation Reproductive toxicity Category 1B
Signal word
Danger
Hazard statements
H319 - Causes serious eye irritation H360 - May damage fertility or the unborn child
Precautionary statements
P264 - Wash face, hands and any exposed skin thoroughly after handling P280 - Wear protective gloves/protective clothing/eye protection/face protection P305 + P351 + P338 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing P337 + P313 - If eye irritation persists: Get medical advice/attention P201 - Obtain special instructions before use P202 - Do not handle until all safety precautions have been read and understood P308 + P313 - IF exposed or concerned: Get medical advice/attention P405 - Store locked up P501 - Dispose of contents/container to an approved waste disposal plant
2.3 Other hazards
Not determined
